Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

ALTERED INSULIN SECRETION PATHWAY (PW:0000677)

View Ontology Report

Description

Type 2 diabetes mellitus (T2D) is reaching epidemic proportions worldwide, yet the genetic underpinnings of the disease continue to be remarkably elusive. The importance and impact of environmental factors such as diet and lifestyle on the susceptibility to the disease only add additional challenges to the identification of genetic causes. While it is known that several pathways important for the maintenance of glucose homeostasis are altered in T2D, less is known about the molecular mech

Pathway Diagram:

Elsevier Inc. ATP-sensitive K+ channels NADPH electron transport chain pathway Rab27a Cdc42 ATP ATP biosynthetic pathway oxidative phosphorylation pathway pyruvate metabolic pathway ---> pyruvate  cycling citric acid cycle pathway pyruvate metabolic pathway glycolysis pathway Gck Slc2a2 membrane depolarization --+> voltage-gated K+ channels Stx1a Munc proteins Syt proteins voltage-gated K+ channels voltage-gated Ca2+ channels Rab3a Vamp2 Snap25 Rho/Rac/Cdc42 mediated signaling pathway Rab family mediated signaling pathway voltage-gated K+ channels ---> membrane repolarization membrane depolarization citric acid cycle pathway ---> pyruvate  cycling voltage-gated Ca2+ channels ---> Ca2+ membrane repolarization glucose-6-P ---> glycolysis pathway D-glucose ---> glucose-6-P pyruvate  cycling Munc proteins ---> Stx1a Snap25 ---- voltage-gated K+ channels elevated glucose levels ---> D-glucose elevated glucose levels D-glucose glucose-6-P Ca2+ membrane depolarization --+> voltage-gated Ca2+ channels membrane repolarization ---| voltage-gated Ca2+ channels Snap25 ---| voltage-gated K+ channels
GO TO:

Genes in Pathway:


show annotations for term's descendants           Sort by:
altered insulin secretion pathway term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc8 ATP binding cassette subfamily C member 8 ISO DNA:missense mutation::A1369S (human) RGD PMID:17259403 RGD:2313628 NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
JBrowse link
G Kcnj11 potassium inwardly-rectifying channel, subfamily J, member 11 ISO polymorphisms in the human gene are linked to altered insulin secretion; E23K polymorphism appears to confer susceptibility to diabetes type-2 in Caucasian population
DNA:missense mutation::p.E23K (human)
RGD PMID:15565284 PMID:17259403 RGD:2313610, RGD:2313628 NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
JBrowse link

Additional Elements in Pathway:

(includes Gene Groups, Small Molecules, Other Pathways..etc.)
Object TypePathway ObjectPathway Object Description
Gene GroupKATPATP-sensitive potassium channels
Gene GroupSytcalcium-binding synaptotagmins
Gene GroupMuncsmunc (stxbp and Unc) proteins
Gene GroupVDCCvoltage-gated calcium channels
Gene GroupKcnvoltage-gated potassium channels

Pathway Gene Annotations

Disease Annotations Associated with Genes in the altered insulin secretion pathway
Disease TermsGene Symbols
atopic dermatitisKcnj11
atrial heart septal defectAbcc8
brain edemaAbcc8
Brain InjuriesAbcc8
cardiac arrestAbcc8
Colorectal NeoplasmsAbcc8
Congenital HyperinsulinismAbcc8 , Kcnj11
congestive heart failureAbcc8
cryptorchidismAbcc8
Developmental Delay, Epilepsy, and Neonatal DiabetesKcnj11
diabetes mellitusAbcc8 , Kcnj11
DwarfismAbcc8
EndotoxemiaAbcc8
Experimental Diabetes MellitusKcnj11
familial hyperinsulinemic hypoglycemia 1Abcc8 , Kcnj11
familial hyperinsulinemic hypoglycemia 2Abcc8 , Kcnj11
gastroesophageal reflux diseaseAbcc8
genetic diseaseAbcc8 , Kcnj11
Growth DisordersAbcc8
hyperinsulinemic hypoglycemiaAbcc8 , Kcnj11
hyperinsulinismAbcc8 , Kcnj11
HyperplasiaAbcc8
hypertensionAbcc8 , Kcnj11
hypoglycemiaAbcc8 , Kcnj11
Insulin ResistanceKcnj11
intellectual disabilityAbcc8 , Kcnj11
Kidney Reperfusion InjuryKcnj11
Left Ventricular HypertrophyKcnj11
leucine-sensitive hypoglycemia of infancyAbcc8 , Kcnj11
MacrocephalyAbcc8
maturity-onset diabetes of the youngAbcc8 , Kcnj11
maturity-onset diabetes of the young type 1Abcc8 , Kcnj11
maturity-onset diabetes of the young type 13Abcc8 , Kcnj11
middle cerebral artery infarctionAbcc8
Muscle HypotoniaAbcc8
Myocardial IschemiaKcnj11
Myocardial Reperfusion InjuryAbcc8 , Kcnj11
NecrosisAbcc8
neonatal diabetesAbcc8 , Kcnj11
Neonatal Hypoglycemia, Simulating Foetopathia DiabeticaAbcc8 , Kcnj11
newborn respiratory distress syndromeAbcc8
obesityAbcc8
ParkinsonismAbcc8 , Kcnj11
permanent neonatal diabetes mellitusAbcc8 , Kcnj11
Permanent Neonatal Diabetes Mellitus 1Kcnj11
Permanent Neonatal Diabetes Mellitus 2Kcnj11
Permanent Neonatal Diabetes Mellitus 3Abcc8 , Kcnj11
polyhydramniosAbcc8
prediabetes syndromeKcnj11
Primary Pulmonary Hypertension, 1Abcc8
Pulmonary Arterial HypertensionAbcc8
RetrognathiaAbcc8
sciatic neuropathyAbcc8 , Kcnj11
Spinal Cord InjuriesAbcc8
status epilepticusAbcc8 , Kcnj11
StrokeAbcc8
Subarachnoid HemorrhageAbcc8
transient neonatal diabetes mellitusAbcc8 , Kcnj11
Transient Neonatal Diabetes Mellitus, 2Abcc8 , Kcnj11
Transient Neonatal Diabetes Mellitus, 3Abcc8 , Kcnj11
Traumatic Subarachnoid HemorrhageAbcc8
type 1 diabetes mellitusAbcc8 , Kcnj11
type 2 diabetes mellitusAbcc8 , Kcnj11
visual epilepsyAbcc8 , Kcnj11
Pathway Annotations Associated with Genes in the altered insulin secretion pathway
Pathway TermsGene Symbols
acebutolol pharmacodynamics pathwayAbcc8 , Kcnj11
adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathwayAbcc8 , Kcnj11
altered insulin secretion pathwayAbcc8 , Kcnj11
amiodarone pharmacodynamics pathwayAbcc8 , Kcnj11
amlodipine pharmacodynamics pathwayAbcc8 , Kcnj11
atenolol pharmacodynamics pathwayAbcc8 , Kcnj11
betaxolol pharmacodynamics pathwayAbcc8 , Kcnj11
bisoprolol pharmacodynamics pathwayAbcc8 , Kcnj11
bupranolol drug pathwayAbcc8 , Kcnj11
bupranolol pharmacodynamics pathwayAbcc8 , Kcnj11
carvedilol pharmacodynamics pathwayAbcc8 , Kcnj11
diabetes mellitus pathwayAbcc8
diltiazem pharmacodynamics pathwayAbcc8 , Kcnj11
disopyramide pharmacodynamics pathwayAbcc8 , Kcnj11
dobutamine pharmacodynamics pathwayAbcc8 , Kcnj11
esmolol pharmacodynamics pathwayAbcc8 , Kcnj11
flecainde pharmacodynamics pathwayAbcc8 , Kcnj11
forkhead class A signaling pathwayAbcc8 , Kcnj11
fosphenytoin pharmacodynamics pathwayAbcc8 , Kcnj11
gliclazide pharmacodynamics pathwayAbcc8
glyburide pharmacodynamics pathwayAbcc8
ibutilide pharmacodynamics pathwayAbcc8 , Kcnj11
insulin secretion pathwayAbcc8 , Kcnj11
isoprenaline pharmacodynamics pathwayAbcc8 , Kcnj11
isradipine pharmacodynamics pathwayAbcc8 , Kcnj11
levobunolol pharmacodynamics pathwayAbcc8 , Kcnj11
lidocaine pharmacodynamics pathwayAbcc8 , Kcnj11
metoprolol pharmacodynamics pathwayAbcc8 , Kcnj11
mexiletine pharmacodynamics pathwayAbcc8 , Kcnj11
nadolol pharmacodynamics pathwayAbcc8 , Kcnj11
nebivolol pharmacodynamics pathwayAbcc8 , Kcnj11
nifedipine pharmacodynamics pathwayAbcc8 , Kcnj11
nimodipine pharmacodynamics pathwayAbcc8 , Kcnj11
nisoldipine pharmacodynamics pathwayAbcc8 , Kcnj11
nitrendipine pharmacodynamics pathwayAbcc8 , Kcnj11
penbutolol pharmacodynamics pathwayAbcc8 , Kcnj11
phenytoin pharmacodynamics pathwayAbcc8 , Kcnj11
pindolol pharmacodynamics pathwayAbcc8 , Kcnj11
potassium channel inhibitors pharmacodynamics pathwayAbcc8
procainamide pharmacodynamics pathwayAbcc8 , Kcnj11
propranolol pharmacodynamics pathwayAbcc8 , Kcnj11
quinidine pharmacodynamics pathwayAbcc8 , Kcnj11
sotalol pharmacodynamics pathwayAbcc8 , Kcnj11
timolol pharmacodynamics pathwayAbcc8 , Kcnj11
type 2 diabetes mellitus pathwayAbcc8 , Kcnj11
verapamil pharmacodynamics pathwayAbcc8 , Kcnj11
Phenotype Annotations Associated with Genes in the altered insulin secretion pathway

References Associated with the altered insulin secretion pathway:

Ontology Path Diagram:

paths to the root
paths to the root

Import into Pathway Studio: